IpamorelinExplore study findings
What mice with impaired growth hormone production revealed about body fat
2 numbered sourcesSource years 1998, 2001
Peptides are short amino-acid chains held together by peptide bonds. A peptide receptor can influence several processes, so the same signal can produce different responses in different systems. Ipamorelin is a synthetic five-residue growth hormone secretagogue and ghrelin-receptor agonist. An older mouse experiment asked whether its effects on body fat depended on growth hormone production. [1, 2]
No recent primary study testing that exact comparison was identified. The investigators compared mice with a genetic form of growth hormone deficiency and mice with intact growth hormone production. They exposed groups to ipamorelin or growth hormone itself and examined body weight, the relative weight of fat pads and, in some animals, body composition measured using X-ray absorptiometry. Ipamorelin increased relative fat-pad weight in mice from both categories under the tested conditions. [1]
The design helps explain the authors' interpretation. If a change appears even in mice with impaired growth hormone production, it raises the possibility that a mechanism other than growth hormone release contributes to it. The researchers also found feeding-related changes in mice with intact growth hormone production exposed to growth hormone secretagogues. These results give a reason to study additional pathways involving the ghrelin receptor and feeding. [1, 2]
Total body weight does not say how much fat or lean tissue an animal has. A change in relative fat-pad weight is also a distinct measurement from an effect on the whole body. This older animal study does not establish a human body composition effect. It shows why a short increase in growth hormone cannot predict every metabolic response to the peptide. [1, 2]
Sources
Original works cited in this article. Links open the external record in a new tab.
